Pfizer to Acquire Anacor Pharmaceuticals for .2 Billion
After terminating deals with AstraZeneca and most recently, Allergan, Pfizer has turned to relatively smaller biotech companies for acquisitions.
Pfizer to Acquire Anacor Pharmaceuticals for .2 Billion
After terminating deals with AstraZeneca and most recently, Allergan, Pfizer has turned to relatively smaller biotech companies for acquisitions.
Op-Ed Contributor: Free Pfizer! Why Inversions Are Good for the U.S.
The new Obama administration rules will ultimately discourage companies from investing in the U.S.
Pfizer to Merge With Allergan in 0 Billion Deal
The agreement would be the latest, and largest, aimed at helping an American company lower its taxes by reincorporating overseas, a tactic known as corporate inversion.
News: Morning Agenda: Pfizer and Allergan Reach 0 Billion Deal
Puerto Rico’s Creditors Open to Debt Exchange | Petco Close to $ 4.7 Billion Sale to CVC and Canadian Pension Fund
Pfizer and Allergan Near 0 Billion Merger Deal
A deal would create a huge new pharmaceutical giant and could potentially help Pfizer lower its American tax rate.
Strategies: A Tax-Cutting Move That Pfizer Can Hardly Resist
The drug maker’s latest move toward shifting its legal tax headquarters abroad has drawn scorn from politicians, but it’s a shareholder-friendly tactic.